115180 — Qurient Share News
0.000.00%
Last trade - 00:00- KR₩877bn
- KR₩860bn
- KR₩7bn
Brief: Qurient To Conduct Capital Increase Of 8 Billion Won For Operational Funds
Brief: Qurient Therapeutics Enters Crada With The National Cancer Institute To Collaborate On A Phase 1/2 Clinical Study Of Q901 In Combination With Trop2-Adc
Brief: Qurient Announces Dosing Of First Patient In Q901 Phase 1/2 Clinical Study For The Treatment Of Patients With Solid Tumors
Brief: Qurient Announces Collaboration Agreement With MSD
Brief: Qurient Announces U.S. FDA Clearance Of Ind Application For Q901, A Novel Cancer Therapy
Brief: Qurient Announces U.S. FDA Clearance Of Ind Application For Q702, A Novel Cancer Immunotherapy
Brief: Quad Investment Management buys stake in Qurient to 13 pct
Brief: Qurient receives patent
Brief: Qurient receives patent
Brief: Qurient receives China patent
Brief: Qurient receives Europe patent
Brief: Qurient receives patent
Brief: Qurient receives patent